Results for tag: "Amyloid Fibrils"

Amyloid Fibrils are a type of protein that are found in the Central Nervous System (CNS). They are associated with a number of neurological diseases, including Alzheimer's, Parkinson's, and Huntington's. As such, they are a major target for drug development in the CNS drugs market. Amyloid Fibrils are formed when proteins misfold and aggregate, forming insoluble fibers. These fibers can cause damage to the CNS, leading to a range of neurological diseases. As such, there is a need for drugs that can target and disrupt the formation of these fibrils. A number of companies are developing drugs to target Amyloid Fibrils. These include AbbVie, Biogen, and Merck. These companies are researching a range of approaches, including small molecule drugs, antibodies, and gene therapy. The aim is to develop treatments that can reduce the formation of Amyloid Fibrils and slow the progression of neurological diseases. Show Less Read more